HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism (Q74692896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Renzo Schiavon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Paolo Battaglia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Emanuela De Fanti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Antonio Fasolin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Stefano Biasioli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Lino Targa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Giancesare Guidi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

39-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

Lipoprotein metabolism and renal failure

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Influence of pregnancy on parathion toxicity and disposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Serum paraoxonase activity is decreased in uremic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Why plasma should not be used to study paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900216-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(02)00216-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204423%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference